Factors Associated With Using the COVID-19 Mobile Contact-Tracing App Among Individuals Diagnosed With SARS-CoV-2 in Amsterdam, the Netherlands: Observational StudyObservational Study Published on 2022-08-242022-10-05 Journal: JMIR mHealth and uHealth [Category] SARS, 임상, [키워드] 95% CI accelerate adjusted odds ratio age AOR B-spline Care caused Characteristics close contact collected component Contact Contact tracing Contact tracing app country COVID-19 COVID-19 pandemic decreased sharply determinant determine diagnosed Digital health diminishe effort employment European Factor feature Gender Health health applications identify individual Infection IQR Isolation less Logistic regression analysis male mathematical model mHealth Mobile Mobile applications mobile contact tracing app multivariable analysis National Netherlands Observational data Older pandemic peaked positive public health reported SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 transmission shown Surveillance was performed [DOI] 10.2196/31099 PMC 바로가기 [Article Type] Observational Study
Association of Different Malnutrition Parameters and Clinical Outcomes among COVID-19 Patients: An Observational StudyObservational Study Published on 2022-08-222022-10-05 Journal: Nutrients [Category] 임상, [키워드] 95% CI adjusted Admission age albumin albumin level Analysis analyzed association body mass index clinical Clinical outcome Comorbidity COVID-19 died Future Gender high risk Hospitalization Hospitalized In-hospital in-hospital mortality in-hospital outcomes increase in increased risk Inpatient IQR male Malnutrition median median age moderate Mortality mortality risk multivariable no risk nutritional risk screening 2002. Odds ratio parameter Patient patient population patients hospitalized patients with COVID-19 prevalent prognostic Regression analyses regression analysis Result risk risk factor Screening secondary endpoint Switzerland Treatment with COVID-19 [DOI] 10.3390/nu14163449 PMC 바로가기 [Article Type] Observational Study
Diaphragm ultrasound evaluation during weaning from mechanical ventilation in COVID-19 patients: a pragmatic, cross-section, multicenter studyCOVID-19 환자의 기계 환기에서 이유 중 횡격막 초음파 평가: 실용적, 횡단면, 다기관 연구Observational Study Published on 2022-08-212022-09-12 Journal: Respiratory Research [Category] 임상, 진단, [키워드] Clinical practice correlated COVID-19 COVID-19 patient Diaphragm diaphragmatic dysfunction enrolled evaluate fraction generalized linear regression hospital ICU information intensive care intensive care units Invasive mechanical ventilation invasive ventilation IQR Italian Mechanical mechanical ventilation multicenter oxygen PaO Patient Pragmatic predict Predictive responsible severe respiratory failure Trial Ultrasound variable weaning Weaning failure. [DOI] 10.1186/s12931-022-02138-y PMC 바로가기 [Article Type] Observational Study
Incidence of thromboembolic complications in hospitalized COVID-19 patients in a medical ward in Japan: A single-center retrospective and prospective observational studyObservational Study Published on 2022-08-192022-10-05 Journal: Medicine [Category] 임상, [키워드] 95% CI addition Admission age Asian Asymptomatic body mass index complications of COVID-19 conducted COVID-19 COVID-19 patient Critical determine died events hallmark higher risk hospital hospitalized COVID-19 patient identify incidence intensive care IQR Ischemia Japan Japanese limb median Mild moderate Myocardial infarction occurred Patient Prevalence Primary outcome prospective cohort study prospective observational study Prospective Study retrospective Severe case severe COVID-19 severe COVID-19 patient severity of COVID-19 single-center stroke symptomatic the median thromboembolic complication thromboembolic complications transferred Venous Thromboembolism women [DOI] 10.1097/MD.0000000000029933 PMC 바로가기 [Article Type] Observational Study
Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients토실리주맙의 적시 투여는 입원한 COVID-19 환자의 결과를 개선합니다Clinical Trial Published on 2022-08-122022-09-12 Journal: PLoS ONE [Category] SARS, 임상, 진단, [키워드] 30-Day mortality 95% CI administration clinical trial Course COVID-19 death determine Dexamethasone disease Efficacy Endpoint enrolled hazard ratio Hospital stay hospitalized COVID-19 patient hospitalized patient ICU IMPROVE IQR Mechanical mechanical ventilation median median age Mortality outcome oxygen support Patient post-hoc analysis primary endpoint Randomized Secondary objective significance level supplemental oxygen Support the disease Tocilizumab treated Treatment Ventilation was performed with COVID-19 [DOI] 10.1371/journal.pone.0271807 PMC 바로가기 [Article Type] Clinical Trial
Nosocomial COVID-19. Prospective study in a referral hospital병원 COVID-19. 의뢰 병원에서의 전향적 연구Case Reports Published on 2022-08-122022-09-11 Journal: Medicina clínica [Category] SARS, 임상, 치료기술, [키워드] Admission Clinical characteristics Comorbidity Control Control de infección coronavirus COVID-19 defined diagnosed Diagnosis died during admission Early detection hospital Hospitalization Hospitalized Infection infection control IQR median median age men Negative PCR nosocomial Nosocomial infection nosocomial outbreak Nosocomial outbreaks Patient patients Pneumonia positive PCR Prevención prevention preventive measure preventive measures Prognosis prognosis of patient Prospective Prospective Study SARS-CoV-2 SARS-COV-2 infection was performed [DOI] 10.1016/j.medcli.2021.07.005 PMC 바로가기 [Article Type] Case Reports
Prevalence, Causes, and Adverse Clinical Impact of Delayed Presentation of Non-COVID-19-Related Emergencies during the COVID-19 Pandemic: Findings from a Multicenter Observational StudyObservational Study Published on 2022-08-092022-10-04 Journal: International Journal of Environmental Research an [Category] 임상, [키워드] 28-day mortality Admission Adverse Bahrain calculate clinical Clinical outcome Comparisons coronavirus disease COVID-19 COVID-19 pandemic Delayed delayed presentation diagnose diagnoses Emergency emergency department enrolled evaluated Factor fear finding group Healthcare system hospital hospitalized patient ICU identify Impact intensive care Invasive mechanical ventilation IQR median Mortality Non-COVID-19 non-COVID-19 emergencies. onset of symptom outcome pandemic Patient patients hospitalized presentation Prevalence Primary outcome regression analysis resulting Saudi Arabia secondary outcome seeking significantly higher study period surgical t-test tertiary care hospital was performed were used [DOI] 10.3390/ijerph19169818 PMC 바로가기 [Article Type] Observational Study
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2전신 자가면역 근병증: SARS-CoV-2에 대한 비활성화된 바이러스 백신의 전향적 4상 대조 시험Clinical Trial Published on 2022-08-032022-09-12 Journal: Rheumatology (Oxford, England) [Category] SARS, 임상, 진단, [키워드] 95%CI adverse event age All participant anti-SARS-CoV-2 anti-SARS-CoV-2 vaccine Autoimmune baseline Comorbidity comparable control group Controlled trial CoronaVac COVID-19 CTRL disease disease status dose drug evaluate Frequency geometric mean titre GMT HIV/AIDS IgG immune response immunogenicity immunogenicity analysis Immunosuppression in both group inactivated interquartile range IQR less median Mild moderate Myopathy myositis Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody parameters participant Patient positive pre-vaccination protocol reduced RT-PCR S1/S2 Safe Safety SAM SARS-CoV-2 SARS-CoV-2 vaccine second dose Seroconversion serology Sex significantly lower systemic therapy Type Vaccine vaccine dose virus were excluded [DOI] 10.1093/rheumatology/keab773 PMC 바로가기 [Article Type] Clinical Trial
Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study60세 이상 성인에서 SARS-CoV-2 BNT162b2 백신 3차 접종에 대한 반응 지속성 3개월 추적: 전향적 코호트 연구Article Published on 2022-08-022022-09-12 Journal: BMJ Open [Category] Coronavirus, SARS, 진단, [키워드] Adverse adverse event Analysis anti-spike IgG level antibody Antibody titre arbitrary unit blood sample BNT162b2 BNT162b2 vaccine CFS clinical cohort study concerning correlated COVID-19 COVID-19 infection defined dose Epidemiology evaluate evaluated events Follow-up healthy IgG IgG level immunology IQR median median age multivariable analysis neutralising neutralising antibody Older participant Patient Prospective prospective cohort study remained reported scale secondary outcome seropositive significantly the SARS-CoV-2 titre titres Vaccine [DOI] 10.1136/bmjopen-2022-061584 PMC 바로가기 [Article Type] Article
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trialChAdOx1 nCoV-19 또는 BNT162b2 2회 접종 및 BNT162b2(COV-BOOST) 3차 접종 후 4차 접종으로 제공된 BNT162b2 및 mRNA-1273 COVID-19 백신의 안전성, 면역원성 및 반응성: 다기관, 맹검, 단계 2, 무작위 시험Clinical Trial Published on 2022-08-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, [키워드] 1:1 95% CI adverse event All participants analysed anti-spike protein IgG assigned blinded block size BNT162b2 boost booster Booster vaccine cellular Cellular and humoral immunity Cellular immune response ChAdOx1 nCoV-19 computer-generated Concentration Controlled trial country COV-BOOST COVID-19 COVID-19 vaccine COVID-19 vaccines dose doses Effectiveness ELISA ELISPOT Endpoint enrolled fatigue female Fold change Fold changes force geometric geometric mean groups Humoral immunity immunogenicity Intramuscular injection IQR ISRCTN Laboratory Local male median age median interval Moderna modified intention-to-treat mRNA mRNA-1273 mRNA-1273 booster mRNA-1273 COVID-19 vaccine multicentre of BNT162b2 outcome participant peak per-protocol population Pfizer-BioNTech Phase 2 random randomisation list randomised controlled trial Randomised trial Randomly reactogenicity receive Registered reported representing response Safety SARS-CoV-2 screened Serious Adverse Event seronegative participant seronegative participants serostatus Seven significant increase statistician T-cell Response T-cell responses Task Force the vaccine the vaccines titre treatment allocation Trial upper arm Vaccine variant were assessed wild-type [DOI] 10.1016/S1473-3099(22)00271-7 PMC 바로가기 [Article Type] Clinical Trial